Drug Profile
SCB 1019
Alternative Names: RSV F antigen vaccine; SCB-1019Latest Information Update: 14 Dec 2023
Price :
$50
*
At a glance
- Originator Clover Biopharmaceuticals
- Class Respiratory syncytial virus vaccines; Synthetic vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- Phase I Respiratory syncytial virus infections